Picture of Aroa Biosurgery logo

ARX Aroa Biosurgery Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Momentum

Relative Strength (%)
1m+17.04%
3m+20.98%
6m-23.72%
1yr-17.69%
Volume Change (%)
10d/3m-23.71%
Price vs... (%)
52w High-27.61%
50d MA+21.7%
200d MA+5.58%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)88.47
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value2.37
Price to Tang. Book2.98
Price to Free Cashflown/a
Price to Sales2.6
EV to EBITDA100.95

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-2.96%
Return on Equity-4.06%
Operating Margin-3.45%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202631st Mar 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of Aroa Biosurgery EPS forecast chart

Profile Summary

Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures, sells, and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Its products are developed from the AROA extracellular matrix (ECM) technology platform, an extracellular matrix biomaterial derived from the ovine forestomach. AROA ECM is an ECM biomaterial containing a rich and complex mix of biological molecules that serve as the building blocks for a range of soft tissue repair products. Its products include Endoform, Myriad Matrix, Myriad Morcells, Myriad Morcells Fine, Symphony, and Reinforced Bioscaffolds. Endoform products support all phases of wound healing and are appropriate for use early in wound management to restore protease balance and advance healing to the proliferative phase. Myriad Matrix is an engineered ECM designed for soft tissue repair, reinforcement, and complex wounds.

Directors

Last Annual
March 31st, 2025
Last Interim
March 31st, 2025
Incorporated
September 21st, 2007
Public Since
July 24th, 2020
No. of Employees
261
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
344,900,256

ARX Share Price Performance

Upcoming Events for ARX

Aroa Biosurgery Ltd Annual Shareholders Meeting

Aroa Biosurgery Ltd Annual Shareholders Meeting

Half Year 2026 Aroa Biosurgery Ltd Earnings Release

Similar to ARX

Picture of 4DMedical logo

4DMedical

au flag iconAustralian Stock Exchange - SEATS

Picture of Adherium logo

Adherium

au flag iconAustralian Stock Exchange - SEATS

Picture of Ansell logo

Ansell

au flag iconAustralian Stock Exchange - SEATS

Picture of Atomo Diagnostics logo

Atomo Diagnostics

au flag iconAustralian Stock Exchange - SEATS

Picture of Austco Healthcare logo

Austco Healthcare

au flag iconAustralian Stock Exchange - SEATS

FAQ